- Home
- REFI vs SMTI Comparison
REFI vs SMTI Comparison
Compare REFI & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REFI
- SMTI
- Stock Information
- Founded
- REFI 2021
- SMTI 1982
- Country
- REFI United States
- SMTI United States
- Employees
- REFI N/A
- SMTI N/A
- Industry
- REFI Real Estate Investment Trusts
- SMTI Medical/Dental Instruments
- Sector
- REFI Real Estate
- SMTI Health Care
- Exchange
- REFI Nasdaq
- SMTI Nasdaq
- Market Cap
- REFI 306.1M
- SMTI 288.2M
- IPO Year
- REFI 2021
- SMTI N/A
- Fundamental
- Price
- REFI $16.21
- SMTI $35.33
- Analyst Decision
- REFI Buy
- SMTI Buy
- Analyst Count
- REFI 2
- SMTI 1
- Target Price
- REFI $20.00
- SMTI $44.00
- AVG Volume (30 Days)
- REFI 76.6K
- SMTI 32.8K
- Earning Date
- REFI 11-07-2024
- SMTI 11-12-2024
- Dividend Yield
- REFI 11.60%
- SMTI N/A
- EPS Growth
- REFI N/A
- SMTI N/A
- EPS
- REFI 2.00
- SMTI N/A
- Revenue
- REFI $56,860,278.00
- SMTI $78,056,873.00
- Revenue This Year
- REFI N/A
- SMTI $29.95
- Revenue Next Year
- REFI $4.27
- SMTI $19.68
- P/E Ratio
- REFI $8.11
- SMTI N/A
- Revenue Growth
- REFI 6.49
- SMTI 24.66
- 52 Week Low
- REFI $14.82
- SMTI $26.00
- 52 Week High
- REFI $17.65
- SMTI $43.25
- Technical
- Relative Strength Index (RSI)
- REFI 64.81
- SMTI 49.41
- Support Level
- REFI $15.96
- SMTI $35.56
- Resistance Level
- REFI $16.23
- SMTI $37.60
- Average True Range (ATR)
- REFI 0.16
- SMTI 1.92
- MACD
- REFI 0.02
- SMTI -0.27
- Stochastic Oscillator
- REFI 97.06
- SMTI 34.86
About REFI Chicago Atlantic Real Estate Finance Inc.
Chicago Atlantic Real Estate Finance Inc is engaged in a commercial real estate finance company. Its primary investment objective is to provide attractive risk-adjusted returns for stockholders over time, through consistent current income dividends and other distributions and secondarily through capital appreciation.
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.